Home Stock

Stock Research: AbbVie

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

AbbVie

NYQ:ABBV US00287Y1091
25
  • Value
    52
  • Growth
    82
  • Safety
    Safety
    21
  • Combined
    52
  • Sentiment
    25
  • 360° View
    360° View
    25
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

AbbVie Inc. is a global biopharmaceutical company focused on research, development, manufacturing, and commercialization of medicines and therapies. Key areas include Immunology, Oncology, Aesthetics, Neuroscience, and Eye Care. In the last fiscal year, the company had a market cap of $329,240 million, profits of $39,430 million, revenue of $56,334 million, and 55000 employees.

more

ANALYSIS: With an Obermatt 360° View of 25 (better than 25% compared with alternatives), overall professional sentiment and financial characteristics for the stock AbbVie are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for AbbVie. The consolidated Value Rank has an attractive rank of 52, which means that the share price of AbbVie is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 52% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 82, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 25. Professional investors are more confident in 75% other stocks. Worryingly, the company has risky financing, with a Safety rank of 21. This means 79% of comparable companies have a safer financing structure than AbbVie. ...read more

more
Strongest Rank Price vs. Book (P/B)
Weakest Rank Dividend Yield
Country USA
Industry Biotechnology
Size XX-Large
Website abbvie.com
Index
D.J. US Health Care
S&P 500
AbbVie stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Jul-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
52 72 n/a n/a
Growth
82 35 n/a n/a
Safety
Safety
21 36 n/a n/a
Sentiment
25 96 n/a n/a
360° View
360° View
25 75 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
14 35 n/a n/a
Opinions Change
50 70 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
53 85 n/a n/a
Sentiment
25 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
52 72 n/a n/a
Growth
82 35 n/a n/a
Safety Safety
21 36 n/a n/a
Combined
52 43 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
49 28 n/a n/a
Price vs. Earnings (P/E)
21 61 n/a n/a
Price vs. Book (P/B)
1 1 n/a n/a
Dividend Yield
100 100 n/a n/a
Value
52 72 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
40 35 n/a n/a
Profit Growth
100 53 n/a n/a
Capital Growth
63 33 n/a n/a
Stock Returns
50 59 n/a n/a
Growth
82 35 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 9 n/a n/a
Refinancing
33 5 n/a n/a
Liquidity
78 92 n/a n/a
Safety Safety
21 36 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to AbbVie and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews